Cytokinetics Inc (CYTK) — Cash Flow Reinvestment Rate
Cytokinetics Inc (CYTK) has a Cash Flow Reinvestment Rate of 3.33x as of December 2020, reinvesting $173.62 Million (capex $6.55 Million plus investments $-167.06 Million) from operating cash flow of $52.15 Million. See Cytokinetics Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cytokinetics Inc Cash Flow Reinvestment Rate (2009–2020)
Historical reinvestment intensity for Cytokinetics Inc across 4 annual periods. For the full cash flow conversion analysis, see Cytokinetics Inc cash flow conversion.
Annual Cash Flow Reinvestment Rate for Cytokinetics Inc (2009–2020)
Year-by-year capital reinvestment analysis for Cytokinetics Inc. See Cytokinetics Inc (CYTK) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 21.97x | $196.51 Million | $8.94 Million | $11.05 Million | ▲ +1459.5% |
| 2016 | 1.41x | $52.11 Million | $36.98 Million | $1.60 Million | ▼ -60.0% |
| 2015 | 3.52x | $17.19 Million | $4.88 Million | $562.00K | ▲ +5285.6% |
| 2009 | 0.07x | $550.00K | $8.42 Million | $550.00K | — |